Vancomycin and zinc: starvation, assembly and resistance

Begin with the cell-wall target

Vancomycin is a glycopeptide antibiotic whose established starting point is recognition of peptide termini used in bacterial cell-wall construction. H. R. Perkins helped establish the chemical specificity in 1969: purified cell-wall precursors formed complexes with vancomycin, and small synthetic peptides showed the importance of an acyl-D-alanyl-D-alanine ending. Chromatography, electrophoresis and ultraviolet spectroscopy made this a molecular recognition problem, rather than merely a correlation between drug exposure and growth inhibition. That contribution still matters when evaluating a proposed additional mechanism: one must explain what metal chemistry changes while preserving the existing evidence for peptide recognition. ^[3]

By binding D-Ala-D-Ala on precursors such as lipid II, vancomycin interferes with the membrane-associated steps that build peptidoglycan. Metal chemistry could modify this established activity or add another physiological effect; it should not erase the cell-wall mechanism. ^[4]

A useful research question therefore has three parts. Does vancomycin bind a metal under defined conditions? Does that interaction change bacterial physiology? Does the physiological change contribute to killing at the concentration and compartment being studied? A binding assay answers the first question. A stress reporter addresses the second. Neither automatically answers the third. The distinction becomes especially productive when the same metal appears to produce opposite outcomes.

What the zinc-starvation experiment established

In 2016, Ashraf Zarkan, Hee-Jeon Hong and colleagues combined bacterial transcription with solution chemistry. Vancomycin induced zinc-responsive genes in three Streptomyces species, Escherichia coli and Bacillus subtilis. The transcription experiment used 2 mM vancomycin for 30 minutes in minimal media supplemented with approximately 3 µM zinc. Affinity chromatography, fluorescence and NMR supported Zn(II) binding. Fluorescence fitting gave a dissociation constant of 1,220 ± 479 µM with 50 µM vancomycin in 100 mM Tris-Cl, pH 7.3. This is weak, condition-specific binding, not a universal intracellular affinity. ^[1]

The E. coli response is particularly informative: zinc-responsive transcription occurred despite the organism's intrinsic exclusion of vancomycin from its usual cell-wall target. The authors proposed that extracellular binding reduces zinc availability. They did not show that zinc starvation causes vancomycin-mediated killing. Their suggestion that cell-surface concentration amplifies weak binding remains a mechanistic hypothesis. ^[1]

This opens a spatial question: could an antibiotic alter the thin chemical environment immediately around a bacterium without measurably depleting the entire culture? Bulk zinc measurements alone cannot decide. Accessible zinc, zinc-regulated transcription and bacterial survival are distinct levels of evidence. Agreement among reported observations would strengthen a mechanistic interpretation; disagreement would reveal an unresolved link. Timing also matters: an early transcriptional response and a later elemental measurement need not describe the same physiological state. Cross-study comparisons should preserve those differences rather than treating every indication of zinc stress as equivalent.

Follow zinc availability, buffering and microbial access →

Why adding zinc can increase activity

Zarkan and colleagues' 2017 follow-up complicates a simple starvation story. Zinc increased susceptibility to vancomycin fourfold in resistant E. faecalis JH2-2::I and eightfold in S. coelicolor M600. Susceptible relatives lacked the enhancement. In engineered S. coelicolor, potentiation tracked use of D-Ala-D-Lac cell-wall precursors, the altered target associated with resistance, rather than D-Ala-D-Ala. The agar experiments used zinc supplementation up to 200 µM for S. coelicolor and 400 µM for E. faecalis. These are culture conditions, not a patient supplementation regimen. ^[2]

Crystallography and fibre diffraction showed zinc-associated assemblies of vancomycin dimers. This supports a drug-assembly explanation for enhanced interaction with the resistant target. However, the study did not solve a vancomycin–zinc–D-Ala-D-Lac ternary structure or demonstrate that the crystallographic polymer exists at an infection site. Its living-cell experiments were bacterial cultures, not animal treatment trials. ^[2]

The two studies need not contradict each other. Removing accessible nutrient and creating an active drug assembly are different possible consequences of the same binding event. Their relative importance could depend on chemical environment and target composition. This is an interpretation to evaluate, not a demonstrated map of clinical behavior. The published findings make the context of each observation central: a zinc-responsive transcript, a crystallographic assembly and a susceptibility change answer different questions. A claim that more chelation must always mean more killing would conceal precisely the distinction worth investigating.

Engineered analogues make different uses of zinc

Venkateswarlu Yarlagadda, Paramita Sarkar and colleagues pursued a deliberate design in 2016: attach a dipicolyl zinc-binding group to vancomycin. Their Dipi-van conjugate acquired recognition of pyrophosphate groups in cell-wall lipids while retaining peptide-terminal binding. The primary abstract reports stronger activity against resistant bacteria and reduced bacterial burden in a mouse kidney infection model. This is an engineered molecule with an additional binding group. It cannot be used as evidence that unmodified vancomycin produces the same effects, or that systemic zinc depletion is the useful mechanism. ^[5]

Sarkar and colleagues subsequently positioned a dipicolylamine-containing substituent at the vancosamine nitrogen, producing VanNHdipi. Their 2024 experiments found cell-wall and membrane effects, inhibition of purified metallo-β-lactamases, and carbapenem potentiation in selected NDM-producing Klebsiella and E. coli isolates. Added zinc abolished a tested meropenem sensitization effect. Yet the derivative alone had MICs above 50 µM against the tested Gram-negative isolates. Thus, combination activity must remain distinct from standalone killing. Docking suggested active-site interactions but did not establish the exact coordination chemistry or prove zinc extraction from the enzyme. ^[4]

These published designs illustrate distinct possibilities: metal can connect a drug to an anionic target, support assembly, or participate in inhibition of a resistance enzyme. Attachment geometry and membrane interactions complicate attribution. Calling every improvement a chelation effect would miss the role of the rest of the molecule. A cross-study assessment should ask whether the evidence actually separates coordination chemistry from these other properties, and identify any mechanistic conclusion that still depends on an unresolved assumption. ^{[5] [4]}

Four comparators that prevent category errors

Chelation describes coordination of a metal through multiple donor atoms of a ligand. It does not specify where the resulting complex travels or what it does. Transport, target recognition and metal mimicry therefore require their own evidence, even when binding chemistry is involved.

Nicoleta Economou and colleagues resolved a bacitracin A–zinc–geranyl-pyrophosphate complex at 1.1 Å. Geranyl pyrophosphate served as a shortened target analogue. The structure illustrates why a metal can be an integral part of molecular recognition: simply stripping it away may dismantle the active complex. It provides a useful design comparison for zinc-linked vancomycin derivatives, while remaining a different antibiotic with a different target interaction. ^[6]

Nichaela Harbison-Price and colleagues showed that PBT2 transports zinc in exchange for protons in liposomes. In Streptococcus uberis NZ01, treatment increased cell-associated zinc and disturbed manganese homeostasis. Transport across a membrane is the crucial distinction from extracellular sequestration. The direction of movement depended on the experimentally imposed gradient, so a molecule's ability to bind zinc does not by itself specify whether a cell gains or loses zinc. ^[7]

Akinobu Ito and colleagues tested cefiderocol in Pseudomonas aeruginosa PAO1 using radiolabeled uptake and an analogue with an altered catechol group. Iron-depleted growth conditions increased drug uptake, and disrupting the iron-binding group reduced activity. The iron-related component facilitates delivery of a cephalosporin; a claim that cefiderocol primarily kills by starving bacteria of iron would misclassify the result. Nutrient acquisition can become a route for drug access. ^[8]

Yukihiro Kaneko and colleagues found that gallium disrupted P. aeruginosa iron uptake and PvdS signaling, with activity in culture and mouse lung infection models. Gallium exploits similarities to ferric iron while lacking iron's physiological redox cycling. But bacterial responses can complicate that strategy. Rodolfo García-Contreras and colleagues later observed increased production of several virulence-associated products in PA14 and two selected clinical isolates exposed to gallium. Biofilm effects depended on strain and observation time. Reduced growth therefore cannot be assumed to mean reduced virulence-factor output in every setting; neither study establishes a universal outcome across infections. ^{[9] [10]}

Compare drug chemistry with host metal withholding and intoxication →

Evidence questions that distinguish the explanations

The most useful endpoint is an explanation that accounts for apparently divergent findings while making its unresolved links visible. A literature comparison can separate what is directly observed from what is inferred: binding, altered transcription, drug assembly, target interaction and clinical outcome belong to different evidentiary levels. Observational measurements from relevant biological compartments could clarify which chemical conditions actually occur there. If the necessary conditions are absent, a mechanism can remain valid in a laboratory preparation while losing relevance to that setting. This approach preserves the scientific opportunity and makes the next evidence gap explicit.

Explore other unexpected metal mechanisms and the experiments they invite →